Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
38.31
+2.83 (7.98%)
At close: Mar 9, 2026, 4:00 PM EDT
39.59
+1.28 (3.34%)
After-hours: Mar 9, 2026, 7:58 PM EDT

Stoke Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
2,1885842353648832,244
Upgrade
Market Cap Growth
372.67%148.73%-35.46%-58.77%-60.67%142.11%
Upgrade
Enterprise Value
1,864320231186522,054
Upgrade
Last Close Price
35.4811.035.269.2323.9961.93
Upgrade
PS Ratio
10.6415.9826.7529.34--
Upgrade
PB Ratio
6.352.551.471.974.057.84
Upgrade
P/TBV Ratio
7.102.551.471.974.057.84
Upgrade
EV/Sales Ratio
9.078.762.679.51--
Upgrade
Debt / Equity Ratio
0.020.020.040.030.020.00
Upgrade
Net Debt / Equity Ratio
-1.05-1.06-1.22-1.22-0.99-1.00
Upgrade
Net Debt / EBITDA Ratio
-11.132.441.732.182.525.49
Upgrade
Net Debt / FCF Ratio
-6.182.782.356.273.156.61
Upgrade
Asset Turnover
0.630.150.040.05--
Upgrade
Quick Ratio
6.215.436.547.3312.8325.15
Upgrade
Current Ratio
6.535.816.997.7713.3725.73
Upgrade
Return on Equity (ROE)
15.02%-45.80%-60.80%-50.20%-34.06%-20.47%
Upgrade
Return on Assets (ROA)
5.20%-25.35%-29.62%-26.36%-20.04%-12.59%
Upgrade
Return on Capital Employed (ROCE)
8.50%-43.80%-58.10%-46.40%-38.80%-18.50%
Upgrade
Earnings Yield
1.85%-15.23%-44.58%-27.77%-9.72%-2.33%
Upgrade
FCF Yield
2.39%-14.90%-35.20%-9.84%-7.72%-1.93%
Upgrade
Buyback Yield / Dilution
-16.83%-22.76%-13.11%-5.87%-9.71%-86.34%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.